Abstract: Methods of developing and using cell lines, such as stem cell lines, for therapeutic or cosmetic use. In one embodiment, the cell lines are used to treat a wide range of degenerative and metabolic disorders including, but not limited to, obesity, diabetes, hypertension, and cardiac deficiency. Also described are methods of using such cell lines to screen for compounds that play a role in regulating a variety of processes.

Abstract: The polymeric carrier for delivering nucleic acid material to a cell is provided herein. The polymeric carrier can include a dendrimer group having 2 to 8 termini, each of the termini having an arginine-grafted bioreducible polymer attached thereto. In one embodiment, only a portion of the termini can have an arginine-grafted bioreducible polymer attached thereto.

Abstract: According to one embodiment of the present disclosure, a circuit includes a Correlated Electron Switch (CES) element and a programming circuit. The CES element includes a first input. The first input of the CES element is coupled to an input signal to be monitored. The CES element is programmed in a first impedance state. The programming circuit coupled to the CES element is configured to switch the CES element from the first impedance state to a second impedance state in response to a voltage transition on the input signal. The voltage transition indicates a fault event. The output element coupled to the first input of the CES element determines that the transition has occurred responsive to the CES element switching to the second impedance state.

Abstract: Disclosed herein, is a bi-functional allosteric protein-drug molecule comprising a targeting moiety, one or more biological binding domains, and one or more therapeutic agents, wherein the therapeutic agent is allosterically bound to the biological binding domain. Also described herein, are methods of incorporating a bi-functional allosteric protein-drug molecule comprising a targeting moiety, one or more biological binding domains that captures the therapeutic agent without the formation of a chemical bond, and one or more therapeutic agents; physiologically acceptable compositions including them; and methods of administering the bi-functional allosteric protein-drug molecule to patients for the treatment of cancer.

Abstract: The disclosure relates to a camera, comprising a housing, an electronics unit comprising a processor, and an image sensor unit comprising an image sensor and a lens support, the electronics unit being fixed inside the housing, the image sensor unit being slidable inside the housing, the housing being provided with a window through which a scene is viewable for the image sensor, the image sensor unit being slidable relative to the housing so as to allow adjustment of a distance between the image sensor and the window along an adjustment direction, wherein the electronics unit and the image sensor unit are connected to each other via a flexible cable for transmittal of digital image sensor output from the image sensor to the processor in the electronics unit.

Abstract: According to one embodiment of the present disclosure, a circuit includes a Correlated Electron Switch (CES) element and a programming circuit. The CES element includes a first input. The first input of the CES element is coupled to an input signal to be monitored. The CES element is programmed in a first impedance state. The programming circuit coupled to the CES element is configured to switch the CES element from the first impedance state to a second impedance state in response to a voltage transition on the input signal. The voltage transition indicates a fault event. The output element coupled to the first input of the CES element determines that the transition has occurred responsive to the CES element switching to the second impedance state.

Abstract: A circuit-carrying assembly for use in an imaging system, the assembly comprising a first circuit carrier; a second circuit carrier spaced apart from the first circuit carrier; at least one attachment member to attach the circuit-carrying assembly to a rigid support member; and a compliant part between the first circuit carrier and the second circuit carrier, the compliant part allowing the second circuit carrier to move towards and away from the first circuit carrier.

Abstract: According to one embodiment of the present disclosure, a circuit includes a Correlated Electron Switch (CES) element and a programming circuit. The CES element includes a first input. The first input of the CES element is coupled to an input signal to be monitored. The CES element is programmed in a first impedance state. The programming circuit coupled to the CES element is configured to switch the CES element from the first impedance state to a second impedance state in response to a voltage transition on the input signal. The voltage transition indicates a fault event. The output element coupled to the first input of the CES element determines that the transition has occurred responsive to the CES element switching to the second impedance state.

Abstract: Described herein are compounds, compositions and methods for modification of the surface of a living cell with a therapeutically relevant targeting moiety. Also described herein are methods for treating disease states, such as acute myocardial ischemia or infarction, with said compositions, in a subject.

Abstract: An integrated circuit includes one or more portions having error detection and error correction circuits and which is operated with operating parameters giving finite non-zero error rate as well as one or more portions formed and operated to provide a zero error rate.

Abstract: An integrated circuit includes one or more portions having error detection and error correction circuits and which is operated with operating parameters giving finite non-zero error rate as well as one or more portions formed and operated to provide a zero error rate.

Abstract: An integrated circuit includes one or more portions having error detection and error correction circuits and which is operated with operating parameters giving finite non-zero error rate as well as one or more portions formed and operated to provide a zero error rate.

Abstract: A circuit-carrying assembly for use in an imaging system, the assembly comprising a first circuit carrier; a second circuit carrier spaced apart from the first circuit carrier; at least one attachment member to attach the circuit-carrying assembly to a rigid support member; and a compliant part between the first circuit carrier and the second circuit carrier, the compliant part allowing the second circuit carrier to move towards and away from the first circuit carrier.

Abstract: A method of controlling data transfer in a data transmission system which includes a plurality of video and/or audio data sources, a single transmitter operable to transmit data from the data sources over at least one transmission channel, a plurality of client receivers operable to receive transmitted data, the method comprising estimating available channel capacity for each client receiver, using parameters relating to the at least one transmission channel, and using information from the transmitter and receiver, and using information relating to queuing of data between the data sources and the transmitter; determining a target bit transmit rate for each client receiver in dependence upon the estimated channel capacity, a quality parameter, and an activity parameter for the client receiver concerned; and controlling the data sources and transmitter in dependence upon the determined bit transmit rate.

Abstract: An integrated circuit includes one or more portions having error detection and error correction circuits and which is operated with operating parameters giving finite non-zero error rate as well as one or more portions formed and operated to provide a zero error rate.

Abstract: Methods of developing and using cell lines, such as stem cell lines, for therapeutic or cosmetic use. In one embodiment the cell lines are used to treat a wide range of degenerative and metabolic disorders including, but not limited to, obesity, diabetes, hypertension, and cardiac deficiency. Also described are methods of using such cell lines to screen for compounds that play a role in regulating a variety of processes.

Abstract: A test chart for characterizing lenses comprises X radial lines extending from a central point and Y concentric X-sided polygons centered at the central point. Each of the X radial lines intersects one vertex of each of the polygons. Each of the X radial lines is divided into Y segments by its intersection points with the central point and with the polygons. The radial lines and the polygons define boundaries of X*Y non-overlapping patches. At least two of the patches share a boundary and are distinctly colored from each other.

Abstract: This invention relates to a method and system of transmitting video data and data to a plurality of client radio receivers over an air interface using an adaptive encoding/transcoding scheme and updating the adaptive encoding/transcoding scheme in dependence upon received feedback data. The invention further describes estimating channel states and distortion levels for a plurality of transmission modes, then selecting that transmission mode for subsequent data transmission that has the lowest distortion level. Control data items can be extracted from the first data stream to produce a multimedia data stream and a control data stream and the multimedia data stream is transmitted over a first channel; the control data stream is transmitted over a second channel.

Abstract: The polymeric carrier for delivering nucleic acid material to a cell is provided herein. The polymeric carrier can include a dendrimer group having 2 to 8 termini, each of the termini having an arginine-grafted bioreducible polymer attached thereto. In one embodiment, only a portion of the termini can have an arginine-grafted bioreducible polymer attached thereto.

Abstract: Methods of developing and using cell lines, such as stem cell lines, for therapeutic or cosmetic use. In one embodiment the cell lines are used to treat a wide range of degenerative and metabolic disorders including, but not limited to, obesity, diabetes, hypertension, and cardiac deficiency. Also described are methods of using such cell lines to screen for compounds that play a role in regulating a variety of processes.